Shealth.AI Secures Investment from XVC Tech

更新於 2024/11/11閱讀時間約 11 分鐘

Dubai, UAE - November 11, 2024 - (SeaPRwire) - Shealth.AI (http://shealth.ai) is proud to announce they have secured investment from XVC Tech. Shealth.AI harnesses advanced Artificial Intelligence (AI) to revolutionize diagnostics, gaining early traction among hospitals and diagnostic center. This milestone marks XVC Tech's first foray into AI-driven healthcare, a natural extension following their success with AI tools like CodeRun.AI, which provides XDC Network developers with comprehensive technical and code generation support. CodeRun.AI has gained popularity among XDC Network developers, helping them build, deploy, and optimize smart contracts and dApps efficiently.

raw-image


XVC Tech, a leading venture capital firm founded by Atul Khekade and Ritesh Kakkad of XDC Network, a $1 billion decentralized computing layer used in applications such as banking, payments, trade finance, and more has made a strategic entry into the healthcare technology sector with its investment in Shealth.AI.

While the valuation details of this investment remain undisclosed, Shealth.AI's MVP is recognized as a game-changer, utilizing AI for rapid and precise diagnostics with nearly 99% accuracy in imaging-based assessments. Hospitals and labs benefit from Shealth.AI's advanced, privacy-focused AI solutions, which are positioned to enhance clinical efficiency and improve patient care outcomes.

A significant driver behind XVC Tech's investment is Shealth.AI's commitment to user data privacy, a crucial factor amid heightened regulations such as the General Data Protection Regulation (GDPR) and other international data protection laws. Unlike many AI healthcare solutions that rely on public or external data storage, Shealth.AI ensures data protection by storing user information securely within the organization's on-premises cloud infrastructure. This approach not only enhances privacy compliance but also provides organizations with full control over their data, aligning perfectly with evolving legal standards in healthcare data protection.

"XVC Tech is thrilled to support Shealth.AI's mission to make healthcare more precise, efficient, and accessible while prioritizing data privacy," said Aneri Merchant, Investment Manager from XVC Tech. She added "Our initial funding and technical guidance have helped Shealth.AI leverage AI to impact the healthcare industry meaningfully. With Shealth.AI's GDPR-compliant infrastructure, hospitals and diagnostics companies can confidently integrate AI into their operations without compromising patient data security."

Ms. Sheetal Chand, Founder and Chief Scientist of Shealth.AI, added, "The support from XVC Tech has been invaluable. Our MVP is already making strides in diagnostic accuracy, and we're just beginning. Together, we aim to revolutionize healthcare diagnostics, enhance patient experiences, and set a new standard for data privacy in healthcare through our advanced AI-driven solutions."

This partnership highlights XVC Tech's dedication to advancing Artificial Intelligence across industries, from XDC Network's developer support tool in blockchain to groundbreaking healthcare innovations, reinforcing their commitment to the future of AI-driven solutions that prioritize data privacy and compliance. Furthermore, XVC Tech is actively seeking strategic partners and co-investors to expand Shealth.AI's groundbreaking technology on a global scale, ensuring the product's transformative potential reaches healthcare systems worldwide.

Shealth.AI is actively open for partnerships with healthcare institutions and hospitals, as well as strategic investment opportunities, to accelerate the integration of its AI-driven diagnostic solutions across the healthcare landscape. This aligns with our vision of collaborative growth, leveraging strategic partnerships to bring Shealth.AI's transformative technology to healthcare providers worldwide.

Contact Details

Sarah Johnson

Director of Communications at Shealth.AI

sarah.johnson@shealth.ai

Website: https://shealth.ai

    avatar-img
    4會員
    330內容數
    留言0
    查看全部
    avatar-img
    發表第一個留言支持創作者!
    EQS Newswire的沙龍 的其他內容
    [11月11日 – 香港] 領先的全球化社交娛樂公司 – 赤子城科技有限公司(「赤子城科技」或「本公司」,股份代號:9911;連同其附屬公司統稱「本集團」)欣然宣佈,10月29至31日,中東北非地區最大的國際投資和創新論壇——第八屆未來投資倡議大會(Future Investment Initiat
    新鴻基有限公司 (香港股份代號:86) (「新鴻基公司」) 宣布推出按揭貸款服務業務。此項業務涉及管理一個近期由機構投資者收購的住宅按揭貸款組合。作為香港具領導地位的非銀行物業按揭貸款服務商,新鴻基公司旗下的新鴻基信貸有限公司(「新鴻基信貸」)將為機構投資者提供全面性行政服務及負責投資組合表現監測及
    At the meeting with the President of Kazakhstan Kassym-Jomart Tokayev, held last week as a part of the 36th plenary session of the Foreign Investors’
    Recently, Chery Group reached a monumental moment in its journey. In four countries—Egypt, Brazil, Kazakhstan, and Malaysia—Chery vehicles rolled off
    The 2024 EXEED Global User Summit was held from October 17 to October 21 in Wuhu, China, celebrating the high-end automotive brand EXEED’s commitment
    Hangzhou, China - November 04, 2024 - (SeaPRwire) - HIKMICRO announced its new 1280x1024 thermal imaging technology through two key products: the STEL
    [11月11日 – 香港] 領先的全球化社交娛樂公司 – 赤子城科技有限公司(「赤子城科技」或「本公司」,股份代號:9911;連同其附屬公司統稱「本集團」)欣然宣佈,10月29至31日,中東北非地區最大的國際投資和創新論壇——第八屆未來投資倡議大會(Future Investment Initiat
    新鴻基有限公司 (香港股份代號:86) (「新鴻基公司」) 宣布推出按揭貸款服務業務。此項業務涉及管理一個近期由機構投資者收購的住宅按揭貸款組合。作為香港具領導地位的非銀行物業按揭貸款服務商,新鴻基公司旗下的新鴻基信貸有限公司(「新鴻基信貸」)將為機構投資者提供全面性行政服務及負責投資組合表現監測及
    At the meeting with the President of Kazakhstan Kassym-Jomart Tokayev, held last week as a part of the 36th plenary session of the Foreign Investors’
    Recently, Chery Group reached a monumental moment in its journey. In four countries—Egypt, Brazil, Kazakhstan, and Malaysia—Chery vehicles rolled off
    The 2024 EXEED Global User Summit was held from October 17 to October 21 in Wuhu, China, celebrating the high-end automotive brand EXEED’s commitment
    Hangzhou, China - November 04, 2024 - (SeaPRwire) - HIKMICRO announced its new 1280x1024 thermal imaging technology through two key products: the STEL
    你可能也想看
    Google News 追蹤
    Thumbnail
    *合作聲明與警語: 本文係由國泰世華銀行邀稿。 證券服務係由國泰世華銀行辦理共同行銷證券經紀開戶業務,定期定額(股)服務由國泰綜合證券提供。   剛出社會的時候,很常在各種 Podcast 或 YouTube 甚至是在朋友間聊天,都會聽到各種市場動態、理財話題,像是:聯準會降息或是近期哪些科
    根据环洋市场咨询机构项目团队最新调研,预计2030年全球医疗设备产值达到479830百万美元,2024-2030年期间年复合增长率CAGR为5.7%。
    0052 富邦科技 0053 元大電子 00728 第一金工業30 00735 國泰臺韓科技 00737 國泰AI+Robo 00757 統一FANG+ 00762 元大全球AI 00770 國泰北美科技 00830 國泰費城半導體 00851 台新全球AI 00861 元大
    Thumbnail
    人工智慧(AI)近年掀起話題,以輝達(Nvidia)為首的 AI 概念股漲勢驚人,而專家看好,雲端企業軟體巨頭 Salesforce 和叫車巨頭 Uber 是兩大尚未漲多的 AI 潛力股。
    Thumbnail
    近日OpenAI與蘋果合作,美國新創產業研究公司PitchBook數據,今年NVIDIA也持續押注,參與韓國新創Twelve Labs的A輪募資,投資約5,000萬美元(約新台幣16億元),大大幫助Twelve Labs開發AI。
    Thumbnail
    6 月 20, 2024 【臨床試驗成果是影響生技產品上市的關鍵,在AI數據技術快速進展下,市場面臨著產品上市的競爭壓力。(圖/橙灝生技顧問提供)】 (記者孟倩玉報導 )    近年來AI數據科學的快速進展,各大藥廠得以加速藥物開發進程,生技市場面臨著產品快速上市的競爭壓力,其中臨床試驗是影響
    Thumbnail
    除現有已知的 AI 硬體建構廠商外,本篇並列出作者對於下一波 AI 應用興起時之潛力企業觀察清單,包含網路服務、網路安全、行業運用方案解決業者、與 AI 軟體開發商等。
    Thumbnail
    在AI風潮席捲下,輝達創辦人黃仁勳多次訪臺,市場傳出他即將出售60萬股自家股票,初估價值7.35億美元,該公司的未平倉空頭押注高達340億美元。臺灣生技醫療卓越的能力受到國際廣泛的認同及讚賞。多所領先同行的生醫企業,共通點都是旅外汲取經驗而成,輝景醫藥集團ABVC就是一前瞻案例。
    Thumbnail
    AI產業已經如2022年預期的到現在都爆發過了 只差在擴散的消費性跟過去發展慢的產業陸續能發酵 接下來就是AI生技的發展 2020~2022年台灣生技醫療很簡單 只要政府有送分題燒錢政策就會有炒作 口罩 快篩 疫情原料藥跟物資 疫苗 遠距需求 "都是政府帶頭尤其有健保加入就是送分題"後面
    Thumbnail
    由05/2023 NVDA 引領的生成式 AI 浪潮至今,若將2023年視為 AI 元年一點也不為過,以臺灣科技實力尤其在矽智財IP與半導體整個大族群串起的上中下游完整完整供應鏈與以傳統伺服器組裝與其周邊關鍵零組件。
    Thumbnail
    *合作聲明與警語: 本文係由國泰世華銀行邀稿。 證券服務係由國泰世華銀行辦理共同行銷證券經紀開戶業務,定期定額(股)服務由國泰綜合證券提供。   剛出社會的時候,很常在各種 Podcast 或 YouTube 甚至是在朋友間聊天,都會聽到各種市場動態、理財話題,像是:聯準會降息或是近期哪些科
    根据环洋市场咨询机构项目团队最新调研,预计2030年全球医疗设备产值达到479830百万美元,2024-2030年期间年复合增长率CAGR为5.7%。
    0052 富邦科技 0053 元大電子 00728 第一金工業30 00735 國泰臺韓科技 00737 國泰AI+Robo 00757 統一FANG+ 00762 元大全球AI 00770 國泰北美科技 00830 國泰費城半導體 00851 台新全球AI 00861 元大
    Thumbnail
    人工智慧(AI)近年掀起話題,以輝達(Nvidia)為首的 AI 概念股漲勢驚人,而專家看好,雲端企業軟體巨頭 Salesforce 和叫車巨頭 Uber 是兩大尚未漲多的 AI 潛力股。
    Thumbnail
    近日OpenAI與蘋果合作,美國新創產業研究公司PitchBook數據,今年NVIDIA也持續押注,參與韓國新創Twelve Labs的A輪募資,投資約5,000萬美元(約新台幣16億元),大大幫助Twelve Labs開發AI。
    Thumbnail
    6 月 20, 2024 【臨床試驗成果是影響生技產品上市的關鍵,在AI數據技術快速進展下,市場面臨著產品上市的競爭壓力。(圖/橙灝生技顧問提供)】 (記者孟倩玉報導 )    近年來AI數據科學的快速進展,各大藥廠得以加速藥物開發進程,生技市場面臨著產品快速上市的競爭壓力,其中臨床試驗是影響
    Thumbnail
    除現有已知的 AI 硬體建構廠商外,本篇並列出作者對於下一波 AI 應用興起時之潛力企業觀察清單,包含網路服務、網路安全、行業運用方案解決業者、與 AI 軟體開發商等。
    Thumbnail
    在AI風潮席捲下,輝達創辦人黃仁勳多次訪臺,市場傳出他即將出售60萬股自家股票,初估價值7.35億美元,該公司的未平倉空頭押注高達340億美元。臺灣生技醫療卓越的能力受到國際廣泛的認同及讚賞。多所領先同行的生醫企業,共通點都是旅外汲取經驗而成,輝景醫藥集團ABVC就是一前瞻案例。
    Thumbnail
    AI產業已經如2022年預期的到現在都爆發過了 只差在擴散的消費性跟過去發展慢的產業陸續能發酵 接下來就是AI生技的發展 2020~2022年台灣生技醫療很簡單 只要政府有送分題燒錢政策就會有炒作 口罩 快篩 疫情原料藥跟物資 疫苗 遠距需求 "都是政府帶頭尤其有健保加入就是送分題"後面
    Thumbnail
    由05/2023 NVDA 引領的生成式 AI 浪潮至今,若將2023年視為 AI 元年一點也不為過,以臺灣科技實力尤其在矽智財IP與半導體整個大族群串起的上中下游完整完整供應鏈與以傳統伺服器組裝與其周邊關鍵零組件。